Evidence map›Paper›PMID 42136616›Full record

Trial reportOpen forum infectious diseases2026

Urinary Tract Infection (UTI)-free and Recurrent UTI (rUTI)-Free Survivals Following Bladder Electrofulguration in Women With a History of Antibiotic-Refractory rUTI.

Stephanie V Armstrong, Amyn A Malik, Feras Alhalabi, Philippe Zimmern

Abstract readClinical Trial
In one paragraph

Trial report in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Stephanie V ArmstrongPeter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA.ORCID https://orcid.org/0009-0006-5407-658X
Amyn A MalikPeter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA.ORCID https://orcid.org/0000-0003-4875-9916
Feras AlhalabiDepartment of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Philippe ZimmernDepartment of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.ORCID https://orcid.org/0000-0002-7612-2042

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Recurrent UTIs (rUTI) contribute to significant morbidity and impaired quality of life. Electrofulguration (EF) of chronic cystitis harboring deep-seated bacteria is an outpatient procedure increasingly considered in antibiotic-refractory rUTI; however, its long-term effectiveness remains understudied. Methods: To evaluate UTI-free and rUTI-free survival following EF we conducted a retrospective cohort study of women with culture-confirmed symptomatic and antibiotic-refractory UTIs who underwent EF between 2006 and 2024. Post-EF UTI and rUTI were defined using standard guideline-based criteria. Kaplan-Meier survival analyses compared survival outcomes by age group and cystitis stage at time of cystoscopy. Multivariable Cox proportional hazards models evaluated independent associations of age and stage with each outcome. Results: During the follow-up period, 291 of 601 patients (48.4%) developed a post-EF UTI. Median time to first UTI was 50 months (95% CI: 40.8-64.8). Increasing age was associated with higher risk of post-EF UTI (aHR = 1.01 per year; 95% CI: 1.00-1.02; Conclusions: Electrofulguration was associated with prolonged UTI-free and rUTI-free survivals among women with antibiotic-refractory rUTI; its effectiveness influenced by cystitis stage and patient age.

Indexed as

disease free survivalelectrofulgurationrecurrent UTIwomen

Identifiers

PMID42136616
PMCPMC13170130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.